(Presentation by Patrick Durisch, The Berne Declaration / Health Action International at the Hearing PACE Committee on Social Affairs, Health and Sustainable Development)

The Problem

  • Misalignment of financial incentives and public health
    • Largely due to the patent-based system
    • Geared towards profit-driven research priorities
    • Monopolies leading to high prices, issues of access to medicines
    • Massive – and sometimes illegal – promotion practices
  • Conflicts of interests
    • Companies design their trials and test their own products, with the risk to maximising benefits and downplaying harm
    • Proximity with authorities, influence power, industry-friendly rules

Read more